Tackling Overprescription: Difference between revisions
Debbie Kenny (talk | contribs) No edit summary |
Debbie Kenny (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
=='''Introduction'''== | =='''Introduction'''== | ||
'' what is the current issue with overprescription and define deprescription'' | '' what is the current issue with overprescription and define deprescription'' | ||
| Line 18: | Line 17: | ||
== Common Populations at Risk == | == Common Populations at Risk == | ||
The use of multiple drugs is not always an indicator of poor drug treatment or overmedication (Tamminga 2011). Appropriate medication depends on whether or not the advantages outweigh the disadvantages which is subjective to both the individual and their given condition(s). It can be very hard to predict the side-effects or clinical effects of a drug combination without testing it on the specific individual as the effects all very based on the individual's genome-specific pharmocokinetics (Taminga 2011). | The use of multiple drugs is not always an indicator of poor drug treatment or overmedication (Tamminga 2011). Appropriate medication depends on whether or not the advantages outweigh the disadvantages which is subjective to both the individual and their given condition(s). It can be very hard to predict the side-effects or clinical effects of a drug combination without testing it on the specific individual as the effects all very based on the individual's genome-specific pharmocokinetics (Taminga 2011). | ||
=== '''1. Elderly Populations''' === | ==== '''1. Elderly Populations''' ==== | ||
As a result of improvements in health care services and modern technology, the aging baby-boomer generation has a longer life-expectancy than previous generations. However, the risk of multiple chronic diseases increases with age requiring multiple medications. Various studies have shown that on average, older adults are consuming 2-9 medication per day with a shocking prevalence of inappropriate medication use of 11.5-62.5% (Hajjar et al. 2007; Kwan et al. 2014). Elderly populations are specifically at risk of adverse drug reactions (ADR) as a result of age related changes such as increased medication sensitivity, slower-metabolism and slower drug elimination. This problem is worsened by increasing the number of drugs used whereby with every added drug, there is a cumulative potential for adverse side-effects and adverse drug interactions (Kwan et al. 2014). What is more worrisome is the fact that signs of polypharmacy are often masked as usual signs and symptoms of aging including: | As a result of improvements in health care services and modern technology, the aging baby-boomer generation has a longer life-expectancy than previous generations. However, the risk of multiple chronic diseases increases with age requiring multiple medications. Various studies have shown that on average, older adults are consuming 2-9 medication per day with a shocking prevalence of inappropriate medication use of 11.5-62.5% (Hajjar et al. 2007; Kwan et al. 2014). Elderly populations are specifically at risk of adverse drug reactions (ADR) as a result of age related changes such as increased medication sensitivity, slower-metabolism and slower drug elimination. This problem is worsened by increasing the number of drugs used whereby with every added drug, there is a cumulative potential for adverse side-effects and adverse drug interactions (Kwan et al. 2014). What is more worrisome is the fact that signs of polypharmacy are often masked as usual signs and symptoms of aging including: | ||
:: Tiredness, decreased alertness, constipation, diarrhea, incontinence, lack of appetite, confusion, depression or lack of interest in usual activities, weakness, visual or auditory hallucinations, anxiety, dizziness | :: Tiredness, decreased alertness, constipation, diarrhea, incontinence, lack of appetite, confusion, depression or lack of interest in usual activities, weakness, visual or auditory hallucinations, anxiety, dizziness. | ||
=== '''2. Psychiatric Patients''' === | :: | ||
=== '''3. Other Populations''' === | ==== '''2. Psychiatric Patients''' ==== | ||
==== '''3. Other Populations''' ==== | |||
== Non-Pharmacological Interventions== | == Non-Pharmacological Interventions== | ||
Revision as of 22:05, 26 March 2018
Introduction[edit | edit source]
what is the current issue with overprescription and define deprescription
Learning Outcomes[edit | edit source]
This resource will enable the reader to:
- Define deprescription and its relevance to the Health Care system
- Explain the role of the physiotherapy profession in deprescription
- Justify the value of deprescription within AHP’s and its application within health care
- Recognize populations at risk of over-prescription and identify common clinical problems/scenarios and medications involved
- Rationalize appropriate non-pharmacological alternatives
- Explain how multidisciplinary teams can work together to better promote/apply deprescription
- Evaluate one’s own practice in relation to the movement of deprescription
Audience[edit | edit source]
This resource is intended for qualified or pre-reg student physiotherapists who are interested in recognizing clinical circumstances of overprescription and further educating themselves on the potential role that could play is addressing this growing issue. All other allied health professionals, academics or individuals interested in the topic are also welcome.
Benefits and Harm of Deprescription[edit | edit source]
Knowledge and Skills Required to Have a Role in Deprescription[edit | edit source]
Common Populations at Risk[edit | edit source]
The use of multiple drugs is not always an indicator of poor drug treatment or overmedication (Tamminga 2011). Appropriate medication depends on whether or not the advantages outweigh the disadvantages which is subjective to both the individual and their given condition(s). It can be very hard to predict the side-effects or clinical effects of a drug combination without testing it on the specific individual as the effects all very based on the individual's genome-specific pharmocokinetics (Taminga 2011).
1. Elderly Populations[edit | edit source]
As a result of improvements in health care services and modern technology, the aging baby-boomer generation has a longer life-expectancy than previous generations. However, the risk of multiple chronic diseases increases with age requiring multiple medications. Various studies have shown that on average, older adults are consuming 2-9 medication per day with a shocking prevalence of inappropriate medication use of 11.5-62.5% (Hajjar et al. 2007; Kwan et al. 2014). Elderly populations are specifically at risk of adverse drug reactions (ADR) as a result of age related changes such as increased medication sensitivity, slower-metabolism and slower drug elimination. This problem is worsened by increasing the number of drugs used whereby with every added drug, there is a cumulative potential for adverse side-effects and adverse drug interactions (Kwan et al. 2014). What is more worrisome is the fact that signs of polypharmacy are often masked as usual signs and symptoms of aging including:
- Tiredness, decreased alertness, constipation, diarrhea, incontinence, lack of appetite, confusion, depression or lack of interest in usual activities, weakness, visual or auditory hallucinations, anxiety, dizziness.
